TrademarkDir
NORTHWEST BIOTHERAPEUTICS
LIVE

Serial Number

76325495

Owner

Northwest Biotherapeutics, Inc.

Attorney

Melissa A. Nowak

First Use Date

Mar 21, 1996

Filing Date

Oct 15, 2001

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NORTHWEST BIOTHERAPEUTICS Trademark

Serial Number: 76325495 • Registration: 2882249

NORTHWEST BIOTHERAPEUTICS is a trademark filed by Northwest Biotherapeutics, Inc. on October 15, 2001. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Northwest Biotherapeutics, Inc. (8 trademarks)

4800 Montgomery Lane, Suite 800
Bethesda, MD 20814

Entity Type: 03

Trademark Details

Filing Date

October 15, 2001

Registration Date

September 7, 2004

First Use Anywhere

March 21, 1996

First Use in Commerce

July 6, 1998

Published for Opposition

August 20, 2002

Goods & Services

Pharmaceutical preparations for use in the treatment of cancer

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jul 28, 2025 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Jul 28, 2025 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 28, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 28, 2025 APRE
TEAS SECTION 8 & 9 RECEIVED
Mar 6, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 7, 2023 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 18, 2014 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 18, 2014 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 18, 2014 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 18, 2014 APRE
TEAS SECTION 8 & 9 RECEIVED
Sep 5, 2014 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 29, 2014 TCCA
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 16, 2010 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 14, 2010 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 31, 2010 E815
REGISTERED-PRINCIPAL REGISTER
Sep 7, 2004 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 22, 2004 CNPR
ASSIGNED TO EXAMINER
Jun 22, 2004 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Jun 21, 2004 SUPC
CASE FILE IN TICRS
Jun 8, 2004 CFIT
PAPER RECEIVED
May 14, 2004 MAIL
USE AMENDMENT FILED
May 11, 2004 IUAF
ASSIGNED TO EXAMINER
Apr 26, 2004 DOCK
SOU EXTENSION 2 GRANTED
Dec 15, 2003 EX2G
PAPER RECEIVED
Nov 17, 2003 MAIL
SOU EXTENSION 2 FILED
Nov 11, 2003 EXT2
SOU EXTENSION 1 GRANTED
Jun 16, 2003 EX1G
SOU EXTENSION 1 FILED
May 2, 2003 EXT1
PAPER RECEIVED
May 2, 2003 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2002 NOAM
PUBLISHED FOR OPPOSITION
Aug 20, 2002 PUBO
NOTICE OF PUBLICATION
Jul 31, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2002 CRFA
NON-FINAL ACTION MAILED
Dec 27, 2001 CNRT
ASSIGNED TO EXAMINER
Dec 14, 2001 DOCK

Related Trademarks

More from this Owner

DCVAX

DCVAX

DCVAX

DCVAX

DCVAX

DCVAX

Trademark logo

Serial #76325361

Trademark logo

Serial #76325361

THE BEST DENDRITIC CELLS IN THE BUSINESS

THE BEST DENDRITIC CELLS IN THE BUSINESS